Logo image of PRZO

PARAZERO TECHNOLOGIES LTD (PRZO) Stock Fundamental Analysis

NASDAQ:PRZO - Nasdaq - IL0011857013 - Common Stock - Currency: USD

1.195  +0.05 (+3.91%)

Fundamental Rating

2

PRZO gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 124 industry peers in the Electronic Equipment, Instruments & Components industry. While PRZO has a great health rating, there are worries on its profitability. PRZO has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

PRZO had negative earnings in the past year.
PRZO Yearly Net Income VS EBIT VS OCF VS FCFPRZO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 -1M -2M -3M

1.2 Ratios

Looking at the Return On Assets, with a value of -52.84%, PRZO is doing worse than 85.00% of the companies in the same industry.
With a Return On Equity value of -91.86%, PRZO is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -52.84%
ROE -91.86%
ROIC N/A
ROA(3y)-101.74%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PRZO Yearly ROA, ROE, ROICPRZO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 100 -100 -200

1.3 Margins

PRZO has a worse Gross Margin (23.19%) than 62.50% of its industry peers.
The Profit Margin and Operating Margin are not available for PRZO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 23.19%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PRZO Yearly Profit, Operating, Gross MarginsPRZO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 -200 -400 -600

More info and screens

7

2. Health

2.1 Basic Checks

PRZO does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for PRZO has been increased compared to 1 year ago.
PRZO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
PRZO Yearly Shares OutstandingPRZO Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2M 4M 6M 8M 10M
PRZO Yearly Total Debt VS Total AssetsPRZO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2M 4M 6M 8M

2.2 Solvency

PRZO has an Altman-Z score of -1.64. This is a bad value and indicates that PRZO is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of PRZO (-1.64) is worse than 81.67% of its industry peers.
PRZO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -1.64
ROIC/WACCN/A
WACC9.21%
PRZO Yearly LT Debt VS Equity VS FCFPRZO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 2M -2M 4M -4M 6M -6M

2.3 Liquidity

A Current Ratio of 5.19 indicates that PRZO has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 5.19, PRZO belongs to the top of the industry, outperforming 85.00% of the companies in the same industry.
PRZO has a Quick Ratio of 4.89. This indicates that PRZO is financially healthy and has no problem in meeting its short term obligations.
PRZO has a Quick ratio of 4.89. This is amongst the best in the industry. PRZO outperforms 87.50% of its industry peers.
Industry RankSector Rank
Current Ratio 5.19
Quick Ratio 4.89
PRZO Yearly Current Assets VS Current LiabilitesPRZO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2M 4M 6M 8M

More info and screens

1

3. Growth

3.1 Past

PRZO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -185.58%.
The Revenue has grown by 10.81% in the past year. This is quite good.
PRZO shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -6.54% yearly.
EPS 1Y (TTM)-185.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-158.63%
Revenue 1Y (TTM)10.81%
Revenue growth 3Y-6.54%
Revenue growth 5YN/A
Sales Q2Q%-18.02%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PRZO Yearly Revenue VS EstimatesPRZO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 200K 400K 600K
PRZO Yearly EPS VS EstimatesPRZO Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

PRZO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PRZO Price Earnings VS Forward Price EarningsPRZO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PRZO Per share dataPRZO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4 -0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

PRZO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PARAZERO TECHNOLOGIES LTD

NASDAQ:PRZO (2/21/2025, 11:29:49 AM)

1.195

+0.05 (+3.91%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners1.14%
Inst Owner ChangeN/A
Ins Owners1.2%
Ins Owner ChangeN/A
Market Cap13.34M
AnalystsN/A
Price TargetN/A
Short Float %10.52%
Short Ratio0.19
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 21.49
P/FCF N/A
P/OCF N/A
P/B 3.25
P/tB 3.25
EV/EBITDA N/A
EPS(TTM)-0.77
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.06
BVpS0.37
TBVpS0.37
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -52.84%
ROE -91.86%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 23.19%
FCFM N/A
ROA(3y)-101.74%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.19
Quick Ratio 4.89
Altman-Z -1.64
F-ScoreN/A
WACC9.21%
ROIC/WACCN/A
Cap/Depr(3y)83.58%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.44%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-185.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-158.63%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)10.81%
Revenue growth 3Y-6.54%
Revenue growth 5YN/A
Sales Q2Q%-18.02%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-69.22%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-49.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-49.15%
OCF growth 3YN/A
OCF growth 5YN/A